Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations

Brooke Sadler, Charles G. Minard, Gabe Haller, Christina A. Gurnett, Sarah H. O'Brien, Allison Wheeler, Shilpa Jain, Mutka Sharma, Ayesha Zia, Roshni Kulkarni, Eric Mullins, Margaret V. Ragni, Robert Sidonio, Jennifer E. Dietrich, Peter A. Kouides, Jorge Di Paola, Lakshmi Srivaths

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Adolescents with low von Willebrand factor (VWF) levels and heavy menstrual bleeding (HMB) experience significant morbidity. There is a need to better characterize these patients genetically and improve our understanding of the pathophysiology of bleeding. We performed whole-exome sequencing on 86 postmenarchal patients diagnosed with low VWF levels (30-50 IU/dL) and HMB and compared them with 660 in-house controls. We compared the number of rare stop-gain/stop-loss and rare ClinVar "pathogenic" variants between cases and controls, as well as performed gene burden and gene-set burden analyses. We found an enrichment in cases of rare stop-gain/stop-loss variants in genes involved in bleeding disorders and an enrichment of rare ClinVar "pathogenic" variants in genes involved in anemias. The 2 most significant genes in the gene burden analysis, CFB and DNASE2, are associated with atypical hemolytic uremia and severe anemia, respectively. VWF also surpassed exome-wide significance in the gene burden analysis (P = 7.31 x 1026). Gene-set burden analysis revealed an enrichment of rare nonsynonymous variants in cases in several hematologically relevant pathways. Further, common variants in FERMT2, a gene involved in the regulation of hemostasis and angiogenesis, surpassed genome-wide significance. We demonstrate that adolescents with HMB and low VWF have an excess of rare nonsynonymous and pathogenic variants in genes involved in bleeding disorders and anemia. Variants of variable penetrance in these genes may contribute to the spectrum of phenotypes observed in patients with HMB and could partially explain the bleeding phenotype. By identifying patients with HMB who possess these variants, we may be able to improve risk stratification and patient outcomes.

Original languageEnglish
Pages (from-to)420-428
Number of pages9
JournalBlood Advances
Volume6
Issue number2
DOIs
StatePublished - Jan 25 2022

Fingerprint

Dive into the research topics of 'Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations'. Together they form a unique fingerprint.

Cite this